FDA Clearance Tracker · P250010
ProlivRx System
Last checked: Nov 19, 2026Latest source record: Dec 31, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Dec 31, 2025
Approved
Time to decision
280 days
Received Mar 26, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P250010
- Device name
- ProlivRx System
- Applicant
- Neurolief , Ltd.
- Applicant location
- Netanya
- Received
- Mar 26, 2025
- Decided
- Dec 31, 2025
- Decision
- Approved
Device type
- Device class
- Class III
- Regulation
- 21 CFR 882.5800
FDA's approval statement
As written in FDA's record.
The ProlivRx System provides focal external Combined Occipital and Trigeminal Afferent Stimulation (eCOT-AS) treatment. It is intended as an adjunctive treatment for Major Depressive Disorder (MDD) in adults who failed to achieve satisfactory improvement from at least one previous antidepressant medication, for use at home or in clinic. It is a prescription-only device.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code JXK. The earliest in FDA's data is P230024, decided Dec 8, 2025.
- It is on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026).
Source documents
Other decisions for Neurolief , Ltd.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Relivion510(k)
K212106 · Decided Aug 2, 2021 · 27 days after receipt
Device type: Stimulator, Nerve, Electrical, Transcutaneous, For Migraine (PCC) · Neurology & Neurosurgery
- Relivion510(k)
K203419 · Decided Feb 16, 2021 · 89 days after receipt
Device type: Stimulator, Nerve, Electrical, Transcutaneous, For Migraine (PCC) · Neurology & Neurosurgery
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.